NSAIDs and the Heart: A Cardiologist's Guide to Ibuprofen, Naproxen, and Cardiovascular Risk

What Are NSAIDs and Why Do Cardiologists Worry About Them?

NSAIDs are anti-inflammatory painkillers that all raise the risk of heart attack, stroke, and heart failure, which is why I pay close attention when a heart patient starts taking them. The abbreviation stands for nonsteroidal anti-inflammatory drugs, a family that includes ibuprofen (sold as Advil and Motrin), naproxen (Aleve), diclofenac (Voltaren), meloxicam (Mobic), indomethacin, ketorolac (Toradol), and the COX-2 selective drug celecoxib (Celebrex).

These are some of the most-used medicines on earth. You can buy most of them without a prescription, and people reach for them for a sore knee, a headache, a bad back, or arthritis without a second thought. That’s the problem. A pill you can grab off a grocery-store shelf feels harmless, and for a young person with no heart trouble it mostly is. For my patients with coronary disease, prior heart attacks, or heart failure, that same pill can tip them into an emergency.

I’m a cardiologist in Encinitas, and this comes up in clinic almost every week. Someone with a stent, or a patient I’m already seeing for chest pain or palpitations, tells me their shoulder has been killing them and they’ve been taking three Advil, three times a day, for a month. They had no idea their heart medication and their pain reliever were pulling in opposite directions. This article lays out what the evidence actually shows about NSAIDs and the heart, which ones are riskier, which are safer, and how to handle pain when your heart is already under strain.

How Do NSAIDs Damage the Heart and Blood Vessels?

NSAIDs harm the cardiovascular system mainly by blocking an enzyme called COX-2, which shifts the balance in your blood vessels toward clotting, higher blood pressure, and fluid retention. The effect is small in a healthy person and dangerous in someone whose heart is already compromised.

Your body makes two related enzymes, COX-1 and COX-2. COX-1 helps protect the stomach lining and helps platelets clump to stop bleeding. COX-2 ramps up during inflammation and, in the lining of your blood vessels, produces a substance called prostacyclin that keeps vessels relaxed and keeps platelets from sticking together. When an NSAID blocks COX-2, you lose some of that protective prostacyclin. The balance tips toward vessels that constrict more easily and blood that clots more readily. That’s the setup for a heart attack or a stroke.

There are three practical consequences I explain to patients. First, blood becomes a little more prone to clotting, so a plaque that ruptures in a coronary artery is more likely to close the vessel off completely. Second, blood pressure tends to rise, often by several points, because these drugs make you hold on to salt and water. Third, that same salt and water retention strains a weak heart, which is why NSAIDs are a classic trigger for a heart failure flare. If you want the fuller picture of how blocked arteries cause damage, I go deeper in my guide to coronary artery disease, my heart attack guide, and my explainer on the coronary artery calcium score.

Do All NSAIDs Raise Heart Risk Equally?

No. All NSAIDs raise heart risk, but the size of the risk varies a lot from drug to drug, and the differences are large enough to change which one I recommend. The big meta-analyses and national cohort studies have sorted these medicines into a rough hierarchy, from most dangerous for the heart to least.

The clearest signal comes from the Coxib and traditional NSAID Trialists’ (CNT) Collaboration, a 2013 analysis in the Lancet that pooled individual data from hundreds of randomized trials. It found that both COX-2 selective drugs and high-dose older NSAIDs raised major vascular events, with naproxen standing out as the exception. Layered on top of that are huge national cohort studies from Denmark and Korea, plus the SOS Project database work across Europe, which let us rank individual drugs.

Here is how the common NSAIDs stack up on heart risk.

Cardiovascular risk by individual NSAID

The takeaway I give patients is simple. Diclofenac and ketorolac sit at the dangerous end, high-dose ibuprofen is a real concern, and naproxen, moderate-dose celecoxib, and meloxicam sit at the safer end. No NSAID is truly free of heart risk.

Why Is Diclofenac Considered the Riskiest Common NSAID?

Diclofenac (Voltaren) carries the highest cardiovascular risk of the widely used oral NSAIDs, with heart-attack and stroke rates that look more like the COX-2 selective drugs than like naproxen or low-dose ibuprofen. It surprises people, because in many countries diclofenac is sold over the counter and prescribed freely for arthritis.

A series of nationwide Danish cohort studies led by Morten Schmidt tracked what happened when people started diclofenac. Starting it raised the rate of major adverse cardiovascular events (heart attack, stroke, and cardiovascular death combined) by about 50% compared with people who took nothing, and by about 20% compared with people who started ibuprofen or acetaminophen. A later Danish emulated-trial series found diclofenac ran about 20% higher for these events than the older COX-2 drugs meloxicam and etodolac. The pattern held even at the doses people actually use.

I call out diclofenac here because the topical gel form, Voltaren gel, is now sold over the counter in the United States and many patients assume the rubbed-on version is risk-free. Applied to one achy joint, the amount absorbed is far lower than a swallowed pill, so the gel is a reasonable option for localized pain. The oral tablets are the ones I steer heart patients away from when an alternative exists.

Is Naproxen the Safest NSAID for Your Heart?

Naproxen (Aleve) has traditionally been the safest NSAID for the heart, and it’s still my usual first pick when a patient with cardiovascular disease truly needs an anti-inflammatory, though newer data have added some caveats. For years, if I had to pick one over-the-counter NSAID for someone with heart disease, it was naproxen.

The reasoning is solid. In the CNT Collaboration analysis, naproxen did not raise major vascular events (relative risk 0.93) or death from vascular causes (relative risk 1.08) compared with placebo. Naproxen has a longer duration of action and a stronger, steadier effect on platelets, which may partly offset the loss of vascular protection that hurts the other NSAIDs. The American Heart Association and European guidelines have long favored it for this reason.

The caveats are worth knowing. A 2017 Bayesian analysis of individual patient data by Michèle Bally found that naproxen, like the others, was linked to a higher heart-attack risk in the first week of use (odds ratio about 1.53). And in a Korean study of patients who had already survived a heart attack, naproxen actually looked worse than celecoxib and meloxicam. So naproxen is the safest bet on average, but “safest NSAID” is not the same as “safe,” and the first week still carries risk. I still counsel the lowest dose for the shortest time even with naproxen.

Are the Newer COX-2 Drugs Like Celecoxib Safer or More Dangerous?

Moderate-dose celecoxib (Celebrex) turned out to be no more dangerous for the heart than ibuprofen or naproxen, which reversed years of assumptions that all COX-2 drugs were heart-hazardous. This is one of the genuine plot twists in this field, and it comes from a single large, careful trial.

The story starts with rofecoxib (Vioxx), a COX-2 drug pulled from the market in 2004 after it clearly raised heart attacks and strokes. That withdrawal tarred the whole COX-2 class. Then came the PRECISION trial, published in 2016 by Steven Nissen and colleagues at the Cleveland Clinic. It randomized 24,081 patients with arthritis who also had heart disease or high heart risk to celecoxib, ibuprofen, or naproxen. Celecoxib at a mean dose of about 209 mg per day was no worse than either older drug for the combined outcome of cardiovascular death, heart attack, or stroke. In the on-treatment analysis it actually had numerically fewer heart events, and it caused fewer stomach and kidney problems too.

There’s an important wrinkle about aspirin. A follow-up analysis by Grant Reed found that celecoxib’s heart advantage showed up mostly in patients who were not taking aspirin. Among aspirin users, all three drugs looked about the same. So moderate-dose celecoxib is a reasonable option, especially for someone who needs daily anti-inflammatory relief, tolerates other drugs poorly, and isn’t already on aspirin. High-dose celecoxib is a different story and has not been shown to be safe.

What About Meloxicam?

Meloxicam (Mobic) has a relatively favorable heart profile and is a reasonable middle-ground choice, though the evidence base is smaller than for naproxen or celecoxib. Meloxicam is partially COX-2 selective at low doses, which sits it somewhere between the old nonselective drugs and the true coxibs.

The best data come from that Korean study of patients recovering from a heart attack, where meloxicam and celecoxib had the best combined heart-and-bleeding safety, while naproxen, ibuprofen, and diclofenac all looked worse in that specific population. The Danish emulated trials also placed meloxicam below diclofenac for event rates. I read meloxicam as a sensible option for a patient who needs once-daily dosing and hasn’t done well on naproxen, with the honest caveat that we have fewer large trials on it.

How Much Do NSAIDs Increase Heart Failure Risk?

NSAIDs roughly double the risk of a heart failure flare, and this holds true for every drug in the class, the newer COX-2 ones and the older ones alike. Of all the heart problems NSAIDs cause, this is the one I see land patients in the hospital most often.

The mechanism is straightforward. NSAIDs make your kidneys hold on to sodium and water. In someone with a healthy heart, the body handles the extra fluid. In someone with heart failure with reduced ejection fraction or heart failure with preserved ejection fraction, that extra fluid backs up into the lungs and legs. Patients come in short of breath, with swollen ankles, having gained five or ten pounds of water weight in a week. Very often the trigger was a new bottle of ibuprofen for a bad back.

The CNT analysis put the number at roughly a doubling of heart failure hospitalizations across the class. For my heart failure patients, this makes NSAIDs close to a hard no. The guidelines agree, and I’d rather manage their pain almost any other way. NSAIDs also blunt the effect of several heart failure and blood pressure drugs, including diuretics, ACE inhibitors, and ARBs, so they undercut the very treatments keeping these patients stable.

Can NSAIDs Raise Your Blood Pressure?

Yes. NSAIDs raise blood pressure, often by several points, and they weaken most blood pressure medications, which matters if you’re already being treated for hypertension. The same salt-and-water retention that triggers heart failure also nudges blood pressure up.

For someone whose blood pressure is well controlled, a regular NSAID habit can undo months of careful adjustment. The rise is usually modest, in the range of 3 to 5 mmHg, but that’s enough to move someone out of goal range, and it compounds over time. NSAIDs blunt ACE inhibitors, ARBs, and diuretics, three of the workhorse blood pressure classes. Long-term, poorly controlled pressure is also hard on the kidneys, which I cover in my article on blood pressure and kidney damage. If you check your pressure at home and see it creeping up after you started a daily pain pill, the pill is a prime suspect.

Does Taking Aspirin Protect You From NSAID Heart Risk?

No. There’s no reliable evidence that a daily aspirin cancels out the clot risk from NSAIDs, and the combination clearly raises your risk of a stomach bleed. This is a common and dangerous assumption, so I want to be direct about it.

People reason that since low-dose aspirin protects the heart, it should offset whatever an NSAID does. It doesn’t work that cleanly. The clot-promoting effect of NSAIDs runs through a different pathway than the one aspirin blocks, and studies have not shown that adding aspirin neutralizes the added heart attack and stroke risk. Worse, ibuprofen taken close to aspirin can physically get in the way of aspirin binding to platelets, so it can blunt the aspirin’s own protective effect. And stacking two drugs that irritate the stomach lining sharply raises the risk of a gastrointestinal bleed. If you take daily aspirin for your heart and you also need an NSAID, that’s a conversation to have with your cardiologist, not a combination to run on your own.

Who Is at the Highest Risk From NSAIDs?

The people most endangered by NSAIDs are those who already have cardiovascular disease, and the added risk climbs with higher doses and longer courses. The proportional jump in risk looks similar across risk groups, but the same percentage increase means far more actual events in someone whose baseline risk is already high.

Highest-risk groups

If you take an anticoagulant like apixaban (Eliquis) or warfarin (Coumadin), adding an NSAID meaningfully raises your bleeding risk, and that’s a combination I watch for carefully. The dose and duration matter as much as the drug. A single ibuprofen for a headache is not the same as 2400 mg a day for a month. Risk rises with the total amount and how long you stay on it, which is exactly why the guiding rule is lowest dose, shortest time.

What Does the Evidence Say About Timing and Dose?

The heart risk from NSAIDs is dose-dependent and can begin within the first week of use, so there’s no safe grace period where a short course carries no risk. This runs counter to the intuition that a quick round of pills must be harmless.

A 2008 study by Luis García Rodríguez showed the risk tracks with dose potency, meaning stronger COX-2 blockade at higher doses translates into more heart events. The Bally analysis of individual patient data showed that heart-attack risk was already elevated in the first week to first month of NSAID use, not just after months of chronic use. Higher doses raised the risk more. That doesn’t mean one pill will hurt you. It means the “just a short course” reassurance isn’t backed by the data, and the safest approach is still the smallest amount that controls your pain for the least time.

What Do the Guidelines Recommend for Pain Relief in Heart Patients?

The AHA and ACC recommend avoiding NSAIDs in people with established cardiovascular disease and using a stepped approach that starts with the safest options first. The guideline framework treats NSAIDs as close to a last resort, not a first reach, when someone’s heart is already involved.

Here is the stepped-care ladder the guidelines lay out for pain in a heart patient.

Stepped-care approach to pain in cardiovascular disease

Acetaminophen is the workhorse here. It isn’t anti-inflammatory the way NSAIDs are, so it won’t do as much for a swollen arthritic joint, but for a lot of everyday pain it’s enough, and it doesn’t carry the heart risk. Topical NSAIDs like Voltaren gel are a good compromise for one painful joint, since far less drug reaches the bloodstream. For chronic arthritis where an oral NSAID is genuinely the only thing that works, I’d rather have that conversation and choose the drug and dose deliberately than have a patient self-treat with whatever is cheapest at the pharmacy.

How Do I Approach NSAIDs in My Encinitas Practice?

In clinic, I start by asking every heart patient what they take for pain, because the honest answer is often an NSAID they never thought to mention. People list their prescriptions carefully and leave off the Advil entirely, because in their mind it isn’t real medicine.

Once I know what someone is taking, the plan depends on their heart. For a patient with heart failure or a recent heart attack, I work hard to get them off oral NSAIDs completely and onto acetaminophen, topical agents, physical therapy, or a pain specialist referral. For a patient with well-controlled risk factors and no established disease, including someone managing metabolic syndrome or diabetes and coronary disease, who needs occasional relief, I’m comfortable with short courses of naproxen at a low dose, and I tell them to check their blood pressure at home. When someone has bad arthritis and nothing but an NSAID touches it, we choose deliberately, usually naproxen or moderate-dose celecoxib, at the lowest dose that works, and we keep an eye on blood pressure, kidney function, and weight.

The through-line is that this should be a decision, not a default. A grocery-store painkiller doesn’t feel like a decision, which is exactly why so many heart patients get into trouble with it. I’d rather spend five minutes on a pain plan in clinic than see them in the hospital with a heart failure flare a month later.

Frequently Asked Questions About NSAIDs and Heart Health

Is Tylenol safer than ibuprofen for your heart?

Yes. Acetaminophen (Tylenol) does not carry the same heart attack, stroke, and heart failure risk that NSAIDs like ibuprofen do, which is why guidelines put it ahead of NSAIDs for pain in heart patients. It isn’t anti-inflammatory, so it works less well for swollen joints, but for most everyday pain it’s the safer choice. Watch your total daily dose to protect your liver, generally staying at or below 3,000 to 4,000 mg per day.

Which NSAID is safest for someone with heart disease?

Naproxen (Aleve) has traditionally been considered the safest NSAID for the heart, and it’s the usual first choice when one is truly needed. Moderate-dose celecoxib (Celebrex) and meloxicam (Mobic) also look reasonable in recent studies. Diclofenac and high-dose ibuprofen carry the most heart risk and are best avoided. Whichever you use, take the lowest dose for the shortest time.

Can ibuprofen cause a heart attack?

Ibuprofen can raise the risk of a heart attack, especially at high doses around 2400 mg per day, where one large analysis found the risk of major coronary events more than doubled. Low, occasional doses carry much less risk. The danger is highest in people who already have heart disease and rises with higher doses and longer use.

How long can I safely take an NSAID?

There’s no fully safe duration, because the heart risk can begin within the first week of use. That said, a short course of a few days for an injury or a flare is far lower risk than daily use for weeks or months. Use the smallest dose that controls your pain and stop as soon as you can. If you find yourself needing an NSAID daily for more than a week or two, talk with your doctor about a longer-term plan.

Does taking aspirin cancel out the heart risk from NSAIDs?

No. There’s no reliable evidence that daily aspirin offsets the clot-promoting effect of NSAIDs, and the combination raises your risk of a stomach bleed. Ibuprofen can also physically interfere with aspirin’s heart-protective effect if taken too close together. If you take aspirin for your heart and also need an NSAID, get a plan from your cardiologist rather than combining them on your own.

Are topical NSAIDs like Voltaren gel safer for the heart?

Topical NSAIDs are generally safer for the heart than the swallowed tablets because far less of the drug reaches your bloodstream. For pain in a single joint, like a knee or a thumb, a topical NSAID such as diclofenac gel is a reasonable option even for many heart patients. The oral tablet form of diclofenac is the one that carries the high cardiovascular risk.

Do NSAIDs interact with blood pressure medications?

Yes. NSAIDs can raise blood pressure by a few points and blunt the effect of several common blood pressure drugs, including ACE inhibitors, ARBs, and diuretics. If your blood pressure has crept up after starting a regular NSAID, the drug is a likely cause. Checking your pressure at home is a good way to catch this.

Why do NSAIDs make heart failure worse?

NSAIDs make the kidneys hold on to sodium and water, and that extra fluid strains a weak heart. In someone with heart failure, this can trigger shortness of breath, leg swelling, rapid weight gain, and a hospital visit. NSAIDs also work against diuretics and other heart failure medications, so they undercut the treatments keeping the condition stable. For most heart failure patients, oral NSAIDs are best avoided entirely.

The Bottom Line

Every NSAID raises heart risk, and the safest way to use one is the lowest dose for the shortest time. If your heart is healthy, occasional low-dose naproxen or ibuprofen for a headache or a sprain is reasonable. If you have coronary disease, a prior heart attack, heart failure, or treated high blood pressure, treat these pills as a real medical decision. Start with non-drug measures and acetaminophen, lean on topical NSAIDs for a single sore joint, and if you need an oral NSAID, choose it with your cardiologist rather than grabbing whatever is on the shelf. Diclofenac tablets and high-dose ibuprofen are the ones to avoid. Come talk to me before you make an NSAID a daily habit, because we almost always have a safer way to handle your pain.

References

1. Minhas, Deeba, Anousheh Nidhaan, and M. Elaine Husni. “Recommendations for the Use of Nonsteroidal Anti-Inflammatory Drugs and Cardiovascular Disease Risk: Decades Later, Any New Lessons Learned?” Rheumatic Diseases Clinics of North America 49, no. 1 (2023): 179-191.

2. Bally, Michèle, Nandini Dendukuri, Benjamin Rich, Lyne Nadeau, Adrian Helin-Salmivaara, Eeva Garbe, and James M. Brophy. “Risk of Acute Myocardial Infarction with NSAIDs in Real World Use: Bayesian Meta-Analysis of Individual Patient Data.” BMJ 357 (2017): j1909.

3. Coxib and traditional NSAID Trialists’ (CNT) Collaboration, Nicola Bhala, Jonathan Emberson, Angela Merhi, et al. “Vascular and Upper Gastrointestinal Effects of Non-Steroidal Anti-Inflammatory Drugs: Meta-Analyses of Individual Participant Data from Randomised Trials.” Lancet 382, no. 9894 (2013): 769-779.

4. Amsterdam, Ezra A., Nanette K. Wenger, Ralph G. Brindis, et al. “2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes.” Journal of the American College of Cardiology 64, no. 24 (2014): e139-e228.

5. Schmidt, Morten, Henrik Toft Sørensen, and Lars Pedersen. “Diclofenac Use and Cardiovascular Risks: Series of Nationwide Cohort Studies.” BMJ 362 (2018): k3426.

6. Schmidt, Morten, Henrik Toft Sørensen, and Lars Pedersen. “Cardiovascular Risks of Diclofenac Versus Other Older COX-2 Inhibitors (Meloxicam and Etodolac) and Newer COX-2 Inhibitors (Celecoxib and Etoricoxib): A Series of Nationwide Emulated Trials.” Drug Safety 45, no. 9 (2022): 983-994.

7. Kang, Dong Oh, Hyonggin An, Gyu Ung Park, et al. “Cardiovascular and Bleeding Risks Associated with Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction.” Journal of the American College of Cardiology 76, no. 5 (2020): 518-529.

8. Masclee, Gwen M. C., Huub Straatman, Andrea Arfè, et al. “Risk of Acute Myocardial Infarction During Use of Individual NSAIDs: A Nested Case-Control Study from the SOS Project.” PLoS One 13, no. 11 (2018): e0204746.

9. Schink, Tania, Bianca Kollhorst, Carlos Varas Lorenzo, et al. “Risk of Ischemic Stroke and the Use of Individual Non-Steroidal Anti-Inflammatory Drugs: A Multi-Country European Database Study Within the SOS Project.” PLoS One 13, no. 9 (2018): e0203362.

10. García Rodríguez, Luis A., Stefania Tacconelli, and Paola Patrignani. “Role of Dose Potency in the Prediction of Risk of Myocardial Infarction Associated with Nonsteroidal Anti-Inflammatory Drugs in the General Population.” Journal of the American College of Cardiology 52, no. 20 (2008): 1628-1636.

11. Nissen, Steven E., Neville D. Yeomans, Daniel H. Solomon, et al. “Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.” New England Journal of Medicine 375, no. 26 (2016): 2519-2529.

12. Reed, Grant W., Mouin S. Abdallah, Mingyuan Shao, et al. “Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen.” Journal of the American College of Cardiology 71, no. 16 (2018): 1741-1751.

Published on damianrasch.com. The above information was composed by Dr. Damian Rasch, drawing on individual insight and bolstered by digital research and writing assistance. The information is for educational purposes only and does not constitute medical advice.